GATEWAY INVESTMENT ADVISERS LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1114618
CINCINNATI, OH
Position in ALNY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$872,987
+$128,199 QoQ
Shares Held
2,900
+28.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#417
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $83,759,285 across 16 Biotechnology names. ALNY ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
365,000 | $38,916,300 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,289 | $33,424,464 | |
| 3 | INCY |
Incyte Corp
|
23,398 | $2,652,397 | |
| 4 | EXEL |
Exelixis, Inc.
|
43,083 | $2,344,146 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
22,728 | $1,300,496 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
4,123 | $993,519 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,900 | $872,987 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
8,111 | $634,847 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $872,987 | 2,900 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $744,788 | 2,251 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $2,044,318 | 5,141 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,344,296 | 5,141 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,920,344 | 5,889 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $1,765,930 | 6,540 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,737,293 | 7,383 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,694,459 | 6,161 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $1,622,511 | 6,677 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $2,845,079 | 19,037 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $3,642,723 | 19,031 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $2,470,722 | 13,951 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $2,195,326 | 11,558 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $2,217,943 | 11,072 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $2,661,917 | 11,201 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $2,189,950 | 10,941 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $3,830,750 | 26,265 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $4,284,566 | 26,239 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $774,641 | 4,568 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $863,616 | 4,574 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $719,442 | 4,244 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $599,210 | 4,244 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $550,292 | 4,234 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $605,259 | 4,157 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $624,876 | 4,219 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $459,238 | 4,219 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||